Burning Rock Biotech Financial Overview
Burning Rock Biotech's market cap is currently $227.98M. The company's EPS TTM is $-0.217; its P/E ratio is -13.17; Burning Rock Biotech is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
